Eliot Choy is counsel in the Corporate Department of the New York office of Latham & Watkins where he focuses on complex commercial transactions involving intellectual property, technology, and pharmaceutical products, with a particular focus on the acquisition, divestiture, development and commercialization of pharmaceutical products.
Mr. Choy has extensive experience in negotiating and drafting a broad range of agreements involving the transfer, use and sharing of intellectual property, including agreements covering the research, development, licensing, supply, manufacturing, promotion and marketing of drug products. He also advises pharmaceutical clients in the settlement of patent litigations.
Mr. Choy serves clients in many industries, including pharmaceuticals, biotechnology, software, and outsourcing, and has negotiated numerous information technology (IT) and real estate outsourcing arrangements and service agreements. In addition, he has experience in advising private and publicly held companies in a variety of corporate transactions, including stock- and asset-based transactions, venture capital and strategic investments and public and private securities offerings.